Back to search
FDAFDA · Food and drugs·Recall number Z-0223-2025

A1CNow+ Multi-Test HbA1c System consists of (1) a semi-disposable plastic-encased device (the monitor), (2) a plastic cartridge enclosing dry reagent strips, and (3) a sample dilution kit for: collecting the blood sample, mixing the sample with the required pre-treatment solution, and delivering the sample to the cartridge.

Published October 30, 2024 · Recall initiated: September 18, 2024

Summary

FDA records medical device Class II recall Z-0223-2025, published October 30, 2024 and initiated September 18, 2024. Recalling firm: Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.; Status: Completed; Reported quantity: 2,452 units; Lot: UDI-DI: 00381933021011 Lot Numbers: 9331803, 2323019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The reason for this recall is PTS Diagnostics, Inc. received complaints of non-matching cartridge and analyzer codes within the product test system box. Use of cartridges and analyzers with non-matching codes may result in inaccurate test results as components within each lot number are meant to be used together, and not mixed between lots. Therefore, the test results may possibly lead to Hemoglobin A1C positive or negative bias results. While the product is for monitoring only, over recovery with a higher than accurate value can be an indication for increased therapy; such as physical activity, weight reduction, meal management, pharmaceutical therapy.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.
Distributor
Worldwide distribution - US Nationwide and the countries of Japan, South Africa.
Lot
UDI-DI: 00381933021011 Lot Numbers: 9331803, 2323019
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was A1CNow+ Multi-Test HbA1c System consists of (1) a semi-disposable plastic-encased device (the monitor), (2) a plastic cartridge enclosing dry reagent strips, and (3) a sample dilution kit for: collecting the blood sample, mixing the sample with the required pre-treatment solution, and delivering the sample to the cartridge. recalled?

Yes. FDA published recall Z-0223-2025 on October 30, 2024. Reported hazard: The reason for this recall is PTS Diagnostics, Inc. received complaints of non-matching cartridge and analyzer codes within the product test system box. Use of cartridges and analyzers with non-matching codes may result in inaccurate test results as components within each lot number are meant to be used together, and not mixed between lots. Therefore, the test results may possibly lead to Hemoglobin A1C positive or negative bias results. While the product is for monitoring only, over recovery with a higher than accurate value can be an indication for increased therapy; such as physical activity, weight reduction, meal management, pharmaceutical therapy.

What should I do if I have this product?

Voluntary: Firm initiated · Letter